Xylem
1,083 hedge funds and large institutions have $32.1B invested in Xylem in 2025 Q3 according to their latest regulatory filings, with 121 funds opening new positions, 414 increasing their positions, 359 reducing their positions, and 86 closing their positions.
41% more first-time investments, than exits
New positions opened: 121 | Existing positions closed: 86
30% more funds holding in top 10
Funds holding in top 10: 10 → 13 (+3)
15% more repeat investments, than reductions
Existing positions increased: 414 | Existing positions reduced: 359
13% more capital invested
Capital invested by funds: $28.3B → $32.1B (+$3.77B)
10% more call options, than puts
Call options by funds: $43.5M | Put options by funds: $39.5M
2% more funds holding
Funds holding: 1,063 → 1,083 (+20)
0.65% less ownership
Funds ownership: 90.05% → 89.4% (-0.65%)
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$172M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$134M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$107M |
| 4 |
Amundi
Paris,
France
|
-$105M |
| 5 |
Axa
Paris,
France
|
-$93.9M |
XYL Hedge Fund Activity: Q3 2025 in Review
1,083 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Xylem (XYL) for Q3 2025, worth a combined $32.1B — up 13% from $28.3B a quarter earlier.
Buyers outnumbered sellers: 121 funds opened new XYL positions and 86 closed out — a net gain of 35 holders — while 414 added to existing stakes and 359 trimmed.
The largest buyer was Schroder Investment Management Group, adding an estimated $158M. The largest seller was T. Rowe Price Associates, cutting an estimated $172M.
- 1,083 institutional investors held Xylem (XYL) as of Q3 2025, up from 1,063 in Q2 2025.
- Funds reported $32.1B of Xylem stock for Q3 2025, up 13% quarter-over-quarter.
- 121 funds opened new Xylem positions in Q3 2025 and 86 closed out, a net change of +35 holders.
- The largest Xylem buyer in Q3 2025 was Schroder Investment Management Group, an estimated $158M added.
- The largest Xylem seller in Q3 2025 was T. Rowe Price Associates, an estimated $172M sold.
Based on aggregated 13F filings for Q3 2025.